|AHFS/Drugs.com||FDA Professional Drug Information|
|Protein binding||High (99%)|
|Elimination half-life||Approximately 8 h (range 4.5–9.8 h) in dogs|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||273.72 g·mol−1|
|3D model (JSmol)|
Carprofen, marketed under many brand names worldwide, is a nonsteroidal anti-inflammatory drug (NSAID) that veterinarians prescribe as a supportive treatment for various conditions in animals. It provides day-to-day treatment for pain and inflammation from various kinds of joint pain as well as post-operative pain. Carprofen reduces inflammation by inhibition of COX-1 and COX-2; its specificity for COX-2 varies from species to species.
Carprofen is 1 of 11 approved NSAID drugs for use in dogs. These are non-steroidal anti-inflammatory drugs that aid in the relief of inflammation, pain, and fever. Carprofen can be administered in a pill, chewable tablet, or injection form.
Often, Carprofen is used as a long-term pain management drug or after a surgical procedure for acute relief of pain and inflammation during the healing process. When using long-term, osteoarthritis is often the targeted condition since it is common in canine patients, varying across breed, size, and age.
For patients in need of acute or chronic pain management, Carprofen is seen to improve energy, activity level, comfort, and general wellbeing of the dog.
Most dogs respond well to carprofen use, but like all NSAIDs, it may cause gastrointestinal, liver and kidney problems in some patients.
In 1999, the FDA had more than 6000 anecdotal reports of sudden animal death after usage of Pfizer’s Rimadyl brand of carprofen. As a result, the FDA requested that Pfizer advise consumers in their advertising that death is a possible side effect. Pfizer refused and pulled their advertising; however, they now include death as a possible side effect on the drug label. Plans call for a "Dear Doctor" letter to advise veterinarians, and a safety sheet attached to pill packages.
Adverse effects should be monitored and brought to your local veterinarian's attention when a patient is on a NSAID for chronic pain management.
Adverse effects include:
- Loss of appetite
- Increase in thirst
- Increase in urination
- Fatigue and/or lethargy (drowsiness)
- Loss of coordination
- Liver dysfunction: jaundice (yellowing of eyes)
- Blood or dark tar-like material in urine or stools
- Staggering, stumbling, weakness or partial paralysis, full paralysis
- Change in skin (redness, scabs, or scratching)
- Change in behavior (such as decreased or increased activity level, seizure or aggression)
In healthy dogs given carprofen, no perioperative adverse effects on the cardiovascular system have been reported at recommended dosages. Perioperative administration of carprofen to cats did not affect postoperative respiratory rate nor heart rate.
Carprofen should not be administered concurrently with steroids, as this can cause ulcers in the stomach. Dogs should be taken off carprofen for three full days before ingesting a steroid (such as prednisolone). Carprofen should not be given at the same time with other types of medications such as other NSAIDs (aspirin, etodolac, deracoxib, meloxicam, tepoxalin) or steroids such as dexamethasone, triamcinolone, cortisone or prednisone.
Carprofen must be used with caution within the supervision of a veterinarian in dogs with liver or kidney disease, dehydration, bleeding deficits, or other health problems. It is not recommended for use in dogs with bleeding disorders (such as Von Willebrand's disease), as safety has not been established in dogs with these disorders. It has not been established whether carprofen can be safely used in pregnant dogs, dogs used for breeding purposes, or in lactating dogs.
Several laboratory studies and clinical trials have been conducted to establish the safety of using Carprofen. Clinical studies were conducted in nearly 300 dogs, coming from different breeds. The dogs were treated with Rimadyl at the recommended dose for 2 weeks. According to these studies, the drug was clinically well tolerated and the treated dogs did not have a greater incidence of adverse reactions when compared to the control group.
A number of factors may contribute to the high incidence of adverse reports received for carprofen by the Center for Veterinary Medicine in the late 1990s. These include:
- The type of drug;
- Wide use;
- Duration of use. Long-term use can result in a higher risk for adverse reactions. It is recommended that blood tests for liver and kidney function are performed both prior to starting and regularly while on NSAIDs to monitor the patient’s tolerance;
- Senior dog use. Older dogs are generally more prone to side effects caused by carprofen.
Carprofen was used in humans for almost 10 years, starting in 1988. It was used for the same conditions as in dogs, viz., joint pain and inflammation. Side effects tended to be mild, usually consisting of nausea or gastro-intestinal pain and diarrhea. Carprofen was available only by prescription in 150 to 600 mg doses. Dosage over 250 mg was only for relieving pain after severe trauma, such as post-surgery inflammation. 150 mg doses were commonly used to relieve the pain of arthritis, while 200 mg doses were commonly prescribed in cases of severe arthritis or severe inflammation pain. The drug was taken orally. Pfizer voluntarily removed it from the market for human use on commercial grounds.
Carprofen may be administered intravenously to horses. A single dose has been shown to reduce prostaglandin E2 production and inflammatory exudate for up to 15 hours, although there was less effect on eicosanoid production when compared to the effects produced by NSAIDs such as phenylbutazone or flunixin. Prostaglandin E2 and inflammatory exudate are also reduced and leukotriene B4 is inhibited. Carprofen can also be given orally, but intramuscular use may produce muscle damage.
Brands and dosage forms for veterinary use
It is marketed under many brand names including: Acticarp, Artriofin, Austiofen, Bomazeal, Canidryl, Carporal, Carprieve, Carprocow, Carprodolor, Carprodyl, Carprofelican, Carprofen, Carprofène, Carprofeno, Carprofenum, Carprogesic, Carprosol, Carprotab, Carprox, Comforion, Dolagis, Dolocarp, Dolox, Eurofen, Kelaprofen, Librevia, Norocarp, Norodyl, Novocox, Ostifen, Prolet, Quellin, Reproval, Rimadyl, Rimifin, Rofeniflex, Rovera, Rycarfa, Scanodyl, Tergive, Vetprofen, and Xelcor.
Veterinary dosage forms include 25 mg, 75 mg, and 100 mg tablets, and 50 mg per mL injectable form.
- Drugs.com International brand names for Carprofen Page accessed October 4, 2017
- Carprofen/Rimadyl (Carprofen) prescribing instructions
- "Animal Drugs @ FDA". animaldrugsatfda.fda.gov. Retrieved 2021-11-16.
- Nov 10, Anna Burke; Nov 10, 2016 | 3 Minutes; Minutes, 2016 | 3. "Rimadyl for Dogs -- Uses, Side Effects & Alternatives". American Kennel Club. Retrieved 2021-11-16.CS1 maint: numeric names: authors list (link)
- "RIMADYL". Zoetis Petcare. Retrieved 2021-11-16.
- Reimer, Michele E.; Johnston, Spencer A.; Leib, Michael S.; Duncan, Robert B.; Reimer, David C.; Marini, Michele; Gimbert, Kimberly (September 1999). "The Gastroduodenal Effects of Buffered Aspirin, Carprofen, and Etodolac in Healthy Dogs". Journal of Veterinary Internal Medicine. 13 (5): 472–477. doi:10.1111/j.1939-1676.1999.tb01465.x. ISSN 0891-6640.
- "Update On Rimadyl". FDA's Center for Veterinary Medicine. December 1, 1999. Archived from the original on September 8, 2014. Retrieved December 16, 2019.
- Luna, Stelio P. L.; Basílio, Ana C.; Steagall, Paulo V. M.; Machado, Luciana P.; Moutinho, Flávia Q.; Takahira, Regina K.; Brandão, Cláudia V. S. (2007-03-01). "Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs". American Journal of Veterinary Research. 68 (3): 258–264. doi:10.2460/ajvr.68.3.258.
- "A Review of Signs of a Potentially Life-threatening Reaction to Rimadyl". Retrieved 2010-05-20.
- "Dog Owner Information About Rimadyl (carprofen)". Retrieved 2010-05-20.
- "Generic Dog Rimadyl Online". Archived from the original on 2011-07-15. Retrieved 2011-07-15.
- Boström IM, Nyman GC, Lord PE, Häggström J, Jones BE, Bohlin HP (May 2002). "Effects of carprofen on renal function and results of serum biochemical and hematologic analyses in anesthetized dogs that had low blood pressure during anesthesia". American Journal of Veterinary Research. 63 (5): 712–21. doi:10.2460/ajvr.2002.63.712. PMID 12013473.
- Frendin JH, Boström IM, Kampa N, Eksell P, Häggström JU, Nyman GC (December 2006). "Effects of carprofen on renal function during medetomidine-propofol-isoflurane anesthesia in dogs". American Journal of Veterinary Research. 67 (12): 1967–73. doi:10.2460/ajvr.67.12.1967. PMID 17144795.
- Höglund OV, Dyall B, Gräsman V, Edner A, Olsson U, Höglund K (October 2018). "Effect of non-steroidal anti-inflammatory drugs on postoperative respiratory and heart rate in cats subjected to ovariohysterectomy". Journal of Feline Medicine and Surgery. 20 (10): 980–84. doi:10.1177/1098612X17742290. PMID 29165006. S2CID 30649716.
- "Rimadyl (Carprofen)". Archived from the original on 2010-05-23. Retrieved 2010-05-20.
- "Rimadyl [package insert]" (PDF). New York: Pfizer Animal Health. 2007. Retrieved 2014-08-13.
- Medicine, Center for Veterinary (2020-11-03). "Get the Facts about Pain Relievers for Pets". FDA.
- Committee for Veterinary Medicinal Products: Carprofen, European Agency for the Evaluation of Medicinal Products
- McIlwraith CW, Frisbie DD, Kawcak CE. Nonsteroidal Anti-Inflammatory Drugs. Proc. AAEP 2001 (47): 182–87.
- Lees P, McKellar Q, May SA, Ludwig B (May 1994). "Pharmacodynamics and pharmacokinetics of carprofen in the horse". Equine Veterinary Journal. 26 (3): 203–08. doi:10.1111/j.2042-3306.1994.tb04370.x. PMID 8542839.
- Lees P, Ewins CP, Taylor JB, Sedgwick AD (1987). "Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin". The British Veterinary Journal. 143 (5): 462–76. doi:10.1016/0007-1935(87)90024-8. PMID 3119142.
- McKellar QA, Bogan JA, von Fellenberg RL, Ludwig B, Cawley GD (July 1991). "Pharmacokinetic, biochemical and tolerance studies on carprofen in the horse". Equine Veterinary Journal. 23 (4): 280–84. doi:10.1111/j.2042-3306.1991.tb03718.x. PMID 1915228.
- Carprofen (Veterinary – Systemic) The United States Pharmacopeial Convention, 2007